Zeyad

a recurring theme. e/acc

[Jon Wu @jonwu_]

It's confusing why a major multi billion dollar law firm is going bankrupt.

So I talked to a bunch of lawyer friends about why Weil could suddenly be insolvent.

Unintuitively, law firms are basically fixed-cost businesses. Revenue comes from a concentrated core group of rainmakers.

Those rainmakers carry the whole business, while the rest of the business basically drags ass. Junior partners are rainmakers-in-training--they can't yet bring in the huge load-bearing dollars.

Everyone else--associates, back office staff--comprises one gigantic fixed cost center. Not to mention basic overhead like offices, revolver interest (for cashflow timing needs), etc.

The problem with law firms in particular, as opposed to other advisory businesses like banking, consulting, accounting, is that the clients are inherently portable.

So any partner can take their team and clients and leave. Doing so deleverages the rest of the partnership, because a small number of partners carry most of the revenue while leaving behind fixed costs.

Once there's a crisis of confidence, it no longer makes sense for partners to stay, because they're now getting underpaid in profit share relative to their revenue potential.

If they were to leave for a megafirm like Kirkland, they'd be properly compensated for their earning potential instead of being saddled by rising fixed costs as a percent of revenue.

There's also not much IP or brand moat in a law firm. Clients follow partners, and the process of crafting exceptional judgment is mostly in partners' heads (versus for instance more regimented value delivery in consulting and banking, where there can be a branded firm process).

And lastly, the partners ARE the equity in the firm. Law firms have no terminal value, so when partners leave it's as if a huge chunk of the firm equity walks out the door.

tl;dr law firm bankruptcy is basically a crisis of partner confidence, and the resulting departure spiral saddles anyone remaining with the gigantic fixed overheads of running a billion-dollar business.

[Anthropic @AnthropicAI]

We’re committing a portion of Anthropic’s shares to the Anthropic Public Benefit Fund, a new wholly owned entity dedicated entirely to the public benefit.

It will start off with 5% of our shares. For every 50% increase in the company’s value over a set baseline, we can contribute up to an extra 2%, subject to our board’s discretion.

In total, this means that roughly 20% of Anthropic’s shares are committed to the public good. Our co-founders have already pledged to donate 80% of their equity, and around half our employees are donating a portion of their equity as part of a donation matching program we’ve run since our founding.

In the post below, we share more details about our new fund.

https://t.co/XzDntVH0vH

[Tesla @Tesla]

Real life, baby

[Neuralink @neuralink]

A beautiful surprise

[signüll @signulll]

there’s something particularly male about turning heartbreak into a cathedral rather than simply explaining that you’re sad.

you build a company. you make an album. you write 900 pages. you conquer france.

absolutely anything except sending the text.

[Hunch Utd @UniqueHunches]

@m0chatyme Apparently he divorced his wife so he can pull off this generational speech

Married to the game

[The Kobeissi Letter @KobeissiLetter]

BREAKING: Moderna stock, $MRNA, surges over +110% after announcing the first ever positive Phase 3 results for a personalized cancer vaccine.

[Zeyad @Zeyadistic]

Wish I could save you permanently. Not for another month, or a few. Wish I could create your cure, somehow.

[Omanta Health @Omantahealth]

Introducing Omanta (YC S26) the personalized research lab for each patient.

Omanta integrates a patient's full medical record, personal genomics, and the latest scientific evidence to understand the molecular drivers of their disease. It maps existing and emerging therapies against their biology. And when the right treatment doesn't exist yet, it launches a personalized campaign to build it.

Even the hardest cases rarely have a team dedicated to solving them. Physicians make high-stakes calls with limited time, while data and therapies emerge every week. Science moves fast, but reaching the patient can take years.

That's the gap Omanta was built to close.

Founders Alfredo Gonzalez, PhD and Ranad Humeidi, PhD spent years on some of the most difficult cancer cases. Alfredo led the personalized therapeutic campaign behind Sid Sijbrandij's complete remission. Together they've worked with leading institutions on personalized vaccines, CAR-T, drug repurposing, expanded access, and continuous molecular monitoring. They've seen what becomes possible when the full force of modern science is organized around one person.

They met eight years ago doing early CRISPR cancer research at the Broad Institute of MIT and Harvard. Alfredo Gonzalez (CEO) has a PhD in bioinformatics from UCLA and led research projects across the Broad Institute, UCLA, and Harvard. Ranad Humeidi (CSO) has a PhD in chemical biology from Harvard, and has built and run rare-cancer programs for individual patients when standard options ran out.

https://t.co/XwNO578Sr6
A research lab, for one.

Linked-in: https://t.co/1Yu7GsxffW
YC Launch: https://t.co/ccZhC854GU

[JT @jiratickets]

zoomers watching their boomer coworker use his brain to formulate an original thought from scratch during a claude outage

[Paul Graham @paulg]

Earnest builders win.

[Liam Gallagher Daily @liamgdaily]

Wonderwall one last time as England WIN against France in the best match of the World Cup! So proud ❤️🏴󠁧󠁢󠁥󠁮󠁧󠁿

[atlas @creatine_cycle]

hey fable nice job on the jacobian conjecture now could you please use the doordash cli to order me popeyes 5-piece chicken tenders

[Adam Cohen @adambcohen93]

Founder friendly VCs in the 90's

[Zeyad @Zeyadistic]

https://t.co/kUq7VOkEXL

[himanshu @himanshustwts]

LMAO

[Daniel @growing_daniel]

You’ll come to San Francisco and meet some of the most evil people on earth and they’ll say things like “your mind is so interesting ☺️”

[Zeyad @Zeyadistic]

A classic. On opportunity cost, balance, and knowing what matters to oneself.

https://t.co/zDtEqYfVgR

[Zeyad @Zeyadistic]

@Motor1com Bold but almost too much overlap with the lambo lineup